您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > MYLS22
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MYLS22
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MYLS22图片
规格:98%
分子量:443.52
包装与价格:
包装价格(元)
5mg电议
10mg电议
50mg电议

产品介绍
MYLS22 是首创的,选择性视神经萎缩 1 (OPA1) 抑制剂。MYLS22 可以靶向内皮细胞 OPA1 减少肿瘤的生长,通过影响 NFkB 活性和血管生成基因表达抑制血管生成。
货号:ajcx29532
CAS:306959-01-3
分子式:C24H21N5O2S
分子量:443.52
溶解度:DMSO: 83.33 mg/mL (187.88 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression[1].


MYLS22 (10 mg/kg/die; peritumoral injection; every 2 days for 14 days) causes the tumor growth curtailed mice[1]. Animal Model: 6-week-old C57BL6/J mice with B16F10 melanomas[1]

[1]. StÉphanie Herkenne, et al. Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1. Cell Metab. 2020 May 5;31(5):987-1003.e8.